Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum: An Open-Label, Single-Arm, Phase 2 Study
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(12)70572-7
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2013
Authors
Publisher
Elsevier BV